Table III.
Protein | Experiment | Company | Cat. no. |
---|---|---|---|
NR2E3 | WB | Proteintech Group, Inc. | 14246-1-AP |
NR2E3 | WB | Santa Cruz Biotechnology, Inc. | sc-374513 |
E-cadherin | WB | ProteinTech Group, Inc. | 20874-1-AP |
N-cadherin | WB | ProteinTech Group, Inc. | 22018-1-AP |
VIMENTIN | WB | Affinity Biosciences, Ltd. | BF8006 |
SLUG | WB | Affinity Biosciences, Ltd. | AF4002 |
NR2C2 | WB | ABclonal Biotech Co., Ltd. | A6422 |
LSD1 | WB | ABclonal Biotech Co., Ltd. | A1156 |
H3K4me2 | WB | ABclonal Biotech Co., Ltd. | A2356 |
GAPDH | WB | ProteinTech Group, Inc. | 60004-1-Ig |
Goat anti-rabbit IgG | WB | Proteintech Group, Inc. | SA00001-2 |
Goat anti-mouse IgG | WB | Proteintech Group, Inc. | SA00001-1 |
CD44-FITC | FCM | Invitrogen; Thermo Fisher Scientific, Inc. | 11-0441-82 |
CD24-PE | FCM | Invitrogen; Thermo Fisher Scientific, Inc. | 12-0247-42 |
NR2E3, nuclear receptor subfamily 2 group E member 3; E-cadherin, cadherin 1; N-cadherin, cadherin 2; NR2C2, nuclear receptor subfamily 2 group C member 2; LSD1, Lysine-specific histone demethylase 1A; H3K4me2, Histone H3 lysine 4 dimethylation; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; WB, western blotting; FCM, flow cytometry.